NovoBiotic

In recent years, many pharmaceutical companies have largely turned their backs on the quest to develop new antibiotics. Out one company bucking the trend is NovoBiotic, which has announced the discovery of a new class of antibiotic that holds promise for treating drug-resistant superbugs.